Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disseminated Malignant Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00055913
What this trial is testing

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+10 more
National Cancer Institute (NCI) 58
Not applicableLooking for participantsNCT06191120
What this trial is testing

FAPI Molecular Imaging for Diagnosis of the CMS4 Unfavorable Colorectal Cancer Subtype

Who this might be right for
Metastatic Colorectal CancerMetastatic Cancer to Liver
UMC Utrecht 45
Early research (Phase 1)Ended earlyNCT05679388
What this trial is testing

Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients

Who this might be right for
Prostate CancerProstate Cancer MetastaticProstate Adenocarcinoma
University of Chicago 60
Not applicableStudy completedNCT05261113
What this trial is testing

CE-IOUS Impact on Surgical Strategy of Liver Tumours and Liver Metastases

Who this might be right for
Liver NeoplasmsLiver/Hepatobiliary CancerColorectal Cancer Metastatic+3 more
University of Regensburg 500
Early research (Phase 1)Looking for participantsNCT06821048
What this trial is testing

Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerStomach CancerPancreatic Cancer+1 more
Weijia Fang, MD 18
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Testing effectiveness (Phase 2)Study completedNCT00006050
What this trial is testing

Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
UNICANCER
Not applicableStudy completedNCT00795678
What this trial is testing

Chemotherapeutic Agents in Brain/Breast

Who this might be right for
Breast CancerMetastatic Cancer
Case Comprehensive Cancer Center 10
Not applicableStudy completedNCT05040685
What this trial is testing

Axillary Reverse Mapping in Breast Cancer

Who this might be right for
Lymph Node Cancer Metastatic
Hospital Universitari de Bellvitge 43
Testing effectiveness (Phase 2)Looking for participantsNCT04068649
What this trial is testing

Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Metastatic Malignant Neoplasm
Roswell Park Cancer Institute 1,500
Large-scale testing (Phase 3)Study completedNCT00104676
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors

Who this might be right for
Extragonadal Germ Cell TumorTeratomaTesticular Germ Cell Tumor
UNICANCER 263
Post-approval studies (Phase 4)Ended earlyNCT01468623
What this trial is testing

Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6

Who this might be right for
Colorectal Cancer, Metastatic
Myriad Genetic Laboratories, Inc. 51
Testing effectiveness (Phase 2)Looking for participantsNCT07007559
What this trial is testing

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer, Metastatic
ALX Oncology Inc. 120
Not applicableLooking for participantsNCT06363773
What this trial is testing

Assess the Ability of Stereotactic Radiotherapy to Restore the Efficacy of Immunotherapy in Patients With Metastatic Cancer.

Who this might be right for
Metastatic Cancer
Elsan 35
Testing effectiveness (Phase 2)Study completedNCT00063960
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 94
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Large-scale testing (Phase 3)Study completedNCT01966003
What this trial is testing

Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Amgen 642
Testing effectiveness (Phase 2)UnknownNCT02976142
What this trial is testing

The Efficacy of Surgical Treatment After Neoadjuvant Chemotherapy Plus Intraperitoneal Immunotherapy Versus Chemotherapy Alone for Patients With Positive Wash Cytology Gastric Cancer

Who this might be right for
Gastric Cancer, Metastatic
Moscow Clinical Scientific Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT05759546
What this trial is testing

PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Fudan University 200
Testing effectiveness (Phase 2)WithdrawnNCT04398927
What this trial is testing

Systemic Chemotherapy Plus PD-1 for Metastasis ICC

Who this might be right for
ICCMetastatic Cancer
Sun Yat-sen University
Next Page